Elevance Health (ELV) Cash from Financing Activities (2010 - 2026)

Elevance Health (ELV) has 17 years of Cash from Financing Activities data on file, last reported at -$2.5 billion in Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$2.5 billion, down 31.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.3 billion (down 213.37% YoY), and the FY2025 annual result was -$1.7 billion, down 245.68% from the prior year.
• Cash from Financing Activities retreated to -$2.5 billion in Q1 2026 per ELV's latest filing, from $236.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $1.4 billion in Q4 2024 and troughed at -$2.5 billion in Q1 2026.
• A 5-year average of -$454.5 million and a median of -$308.0 million in 2025 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 457.36% in 2024, then plunged 6065.62% in 2025.
• A 5-year view of Cash from Financing Activities shows it stood at -$258.0 million in 2022, then sank by 52.71% to -$394.0 million in 2023, then surged by 457.36% to $1.4 billion in 2024, then slumped by 83.24% to $236.0 million in 2025, then sank by 1165.68% to -$2.5 billion in 2026.
• Business Quant data shows ELV's Cash from Financing Activities at -$2.5 billion in Q1 2026, $236.0 million in Q4 2025, and $243.0 million in Q3 2025.